Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Recruiting · NCT07223229 · Registry updated 2026-06-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients | Non-segmental Vitiligo | Recruiting | Phase 2 | 2026-06-05 | NCT07223229 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Elixiron Immunotherapeutics (Hong Kong) Ltd. | 1 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Apex Clinical Research Center, LLC (Mayfield) | Mayfield Heights | United States | 1 |
| Center for Clinical Studies | Houston | United States | 6 |
| Linkou Chang Gung Memorial Hospital | Taoyuan | Taiwan | 7 |
| Marvel Clinical Research | Huntington Beach | United States | 1 |
| Skin Care Research, LLC | Hollywood | United States | 3 |
| U Mass Chan Medical School | Worcester | United States | 1 |